Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs).
Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs).
复制标题
DOI：
10.1177/0333102417731348
复制
发表时间：
2018-06
期刊：
影响因子：
--
通讯作者：
Underwood M
中科院分区：
文献类型：
--
作者：
Haywood KL;Mars TS;Potter R;Patel S;Matharu M;Underwood M
批判性评价、比较和综合慢性或发作性头痛成人患者报告的多项结局指标的质量和可接受性。对主要数据库（1980-2016）进行系统性文献检索，以识别PROM测量和实际特性的已发表证据。提取研究质量（COSMIN）、测量和每项测量的实际属性数据，并根据公认的标准进行评估，以提供证据合成。在10，903篇综述摘要中，对103篇文章进行了全面评估; 46篇文章为23项PROM提供了证据：11篇针对偏头痛（n = 5）或头痛（n = 6）的健康相关影响; 6篇评估了偏头痛特定的治疗反应/满意度; 6篇为通用指标。两项影响指标，偏头痛特异性生活质量问卷（MSQ v2.1）和头痛影响测试6项（HIT-6），以及治疗反应之一，偏头痛患者感知问卷（PPMQ-R）的测量有效性和评分解释证据最强。可靠性的证据是有限的，但可以接受的HIT-6。很少评价反应性。其余措施的证据有限。患者参与有限且报告不多。虽然证据有限，但有三项测量具有可接受的可靠性和有效性证据：HIT-6，MSQ v2.1和PPMQ-R。只有HIT-6有可接受的证据支持所有“头痛”人群完成。
To critically appraise, compare and synthesise the quality and acceptability of multi-item patient reported outcome measures for adults with chronic or episodic headache. Systematic literature searches of major databases (1980–2016) to identify published evidence of PROM measurement and practical properties. Data on study quality (COSMIN), measurement and practical properties per measure were extracted and assessed against accepted standards to inform an evidence synthesis. From 10,903 reviewed abstracts, 103 articles were assessed in full; 46 provided evidence for 23 PROMs: Eleven specific to the health-related impact of migraine (n = 5) or headache (n = 6); six assessed migraine-specific treatment response/satisfaction; six were generic measures. Evidence for measurement validity and score interpretation was strongest for two measures of impact, Migraine-Specific Quality of Life Questionnaire (MSQ v2.1) and Headache Impact Test 6-item (HIT-6), and one of treatment response, the Patient Perception of Migraine Questionnaire (PPMQ-R). Evidence of reliability was limited, but acceptable for the HIT-6. Responsiveness was rarely evaluated. Evidence for the remaining measures was limited. Patient involvement was limited and poorly reported. While evidence is limited, three measures have acceptable evidence of reliability and validity: HIT-6, MSQ v2.1 and PPMQ-R. Only the HIT-6 has acceptable evidence supporting its completion by all “headache” populations.
登录
查看更多内容
影响因子：
3.6
作者：
Bakas T;McLennon SM;Carpenter JS;Buelow JM;Otte JL;Hanna KM;Ellett ML;Hadler KA;Welch JL
通讯作者：
Welch JL
影响因子：
5
作者：
Coon, Cheryl D.;Fehnel, Sheri E.;Cady, Roger K.
通讯作者：
Cady, Roger K.
影响因子：
3
作者：
Feeny, D;Furlong, W;Boyle, M
通讯作者：
Boyle, M
影响因子：
5
作者：
Andrasik, F;Lipchik, GL;Wittrock, DA
通讯作者：
Wittrock, DA
影响因子：
4.5
作者：
Brown, Jeffrey S.;Neumann, Peter J.;Menzin, Joseph
通讯作者：
Menzin, Joseph